SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is actively trending ahead of its earnings report, sparking a widespread debate among investors on whether it will follow the recent "sell the news" pattern seen with other AI chip stocks, or if its robust custom silicon and AI networking demand will drive a rally. The community is closely watching its AI revenue growth and guidance, with some optimistic about its core business in data center infrastructure and others concerned about broader market sentiment and hyperscaler spending trends.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending ahead of its Q4 earnings report, with community sentiment largely negative due to sustained underperformance and price declines, even as some investors highlight its low valuation, substantial cash reserves, and strategic competitive advantages within the Chinese e-commerce sector.

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals is trending amidst fervent buyout speculation, fueled by recent volume spikes and rumors of potential acquisition by suitors such as Jazz Pharmaceuticals or Ipsen. The community is actively debating a potential takeover, with many believing the company's strong oncology pipeline, including OJEMDA and the Mersana acquisition, and current valuation make it an attractive target in an active M&A market.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending after securing a $2.4 billion contract to build a 1.2-gigawatt natural gas plant for Applied Digital's AI data centers, a deal widely regarded as transformational given its magnitude relative to the company's market capitalization. The community is actively discussing BW's strong position to rapidly deliver critical power solutions for the booming AI infrastructure, with potential for further substantial projects.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is experiencing significant momentum driven by a slew of new mobile network operator partnerships, including Telus becoming an equity shareholder, alongside strong analyst upgrades and solid revenue performance. The community is buzzing with short squeeze potential and high future valuation expectations for its direct-to-device satellite technology, especially given its strong relative strength in the current market.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is surging as a substantial patent settlement removes a major legal overhang, while the FDA's reversal to review its flu vaccine application is driving bullish sentiment and sparking community talk of a massive short squeeze, with attention now turning to its promising oncology pipeline.

BlackRock Institutional Trust Company N.A. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF is highly volatile amid geopolitical concerns that triggered market circuit breakers; however, robust underlying demand for AI-driven memory chips from major holdings like Samsung and SK Hynix is fueling a strong rebound, leading community discussion on whether initial market fear was overblown.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic (LUNC) is trending due to Binance's recent token burn, which is fueling community optimism about supply reduction and a potential price surge. This comes as the market also processes Do Kwon's sentencing, sparking debate among investors regarding its varied long-term implications for LUNC's recovery and ongoing ecosystem developments.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini's new prediction market is live, supported by its CFTC Designated Contract Market (DCM) license, sparking community excitement as it enters this competitive sector. High short interest and rising borrow rates are simultaneously fueling short squeeze speculation.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is navigating market volatility following its recent earnings beat and raised guidance, which was initially met with skepticism over AI disruption fears but was bolstered by a newly authorized share buyback program. The community is sharply divided between frustration over perceived price manipulation and strong conviction in the company's long-term opportunity in securing AI agents, despite broader sector concerns about new AI tools.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stevanato Group Q4 Earnings Call Highlights

Stevanato Group (NYSE:STVN) executives said the company closed fiscal 2025 with solid results and entered 2026 with positive momentum, driven by continued strength in its Biopharmaceutical and...

Stevanato Group (NYSE:STVN) Shares Gap Up - Here's Why

Stevanato Group (NYSE:STVN) Shares Gap Up - Still a Buy...

Stevanato Group (NYSE:STVN) Releases Earnings Results, Misses Expectations By $0.03 EPS

Stevanato Group (NYSE:STVN - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported 0.17 EPS for the quarter, missing the consensus estimate of 0.20 by ( 0.03...

Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates

Stevanato (STVN) delivered earnings and revenue surprises of +6.06% and +4.96%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Stevanato Group (NYSE:STVN) Updates FY 2026 Earnings Guidance

Stevanato Group (NYSE:STVN) updated its FY 2026 earnings guidance. The company provided EPS guidance of 0.690-0.730 for the period, compared to the consensus estimate of 0.730. The company also...

Stevanato Group Expects Annual Results To Improve; Stock Up 5% In Pre-Market

(RTTNews) - Stevanato Group S.p.A. (STVN), an Italian provider of industrial drug containment, drug delivery, and diagnostic solutions, on Wednesday initiated guidance for the full year...

Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today...

Indivior Pharmaceuticals Inc. (INDV) Tops Q4 Earnings and Revenue Estimates

Indivior Pharmaceuticals Inc. (INDV) delivered earnings and revenue surprises of +26.80% and +17.15%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries...

Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) has been given an average recommendation of "Moderate Buy" by the five ratings firms that are currently covering the stock, MarketBeat.com...

$STVN Q4 &#39;25 Earnings Results &amp; Recap

Stevanato Group expects fiscal 2026 revenue between 1.26B and 1.29B, adjusted EBITDA from 331.8M to 346.9M, and adjusted diluted EPS in the range of 0.59 to 0.63.

Stocktwits

Stevanato Group Spa

 Q4 '25 Earnings Results & Recap

Stevanato Group expects fiscal 2026 revenue between 1.26B and 1.29B, adjusted EBITDA from 331.8M to 346.9M, and adjusted diluted EPS in the range of 0.59 to 0.63.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.

STVN
Stevanato Group Spa

Feed

News

Sentiment

Earnings

Fundamentals

Info

Earnings Recap

Latest STVN News

STVNStevanato Group Spa